Categories: News

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and fiscal year-end financial results before the markets open on Friday, March 7, 2025.

Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following:

Toll free (U.S.) 1-833-316-0561
International (U.S) 1-412-317-0690
Germany 0800-6647650
Israel 1-80-9212373
Access Code Please reference the “Lifeward Earnings Call”

The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the “Investors” section, or through the following link: https://edge.media-server.com/mmc/p/9u4xjdep. An archived webcast will also be available on the company’s website.

About Lifeward

Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the ReStore Exo-Suit, and the MyoCycle FES System.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.

Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.   

Lifeward Media Relations:
Kathleen O’Donnell
VP Marketing & New Business Development
Lifeward Ltd.
E: media@golifeward.com

Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward Ltd.
E: ir@golifeward.com

Staff

Recent Posts

Glytec Software Wins “Best Computerized Decision Support Solution” in 2025 MedTech Breakthrough Awards Program

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies…

1 hour ago

TrustCommerce, a Sphere Company, Wins MedTech Breakthrough Award for Payment Innovation

Healthcare financial technology company wins for Cloud Payments solution   CHICAGO, May 8, 2025 /PRNewswire/…

1 hour ago

Amavita Heart and Vascular Health Achieves Two Prestigious IAOCR Certifications

MIAMI, May 8, 2025 /PRNewswire/ -- Amavita Heart and Vascular Research Services LLC the research…

1 hour ago

Covera Health Expands Radiology Centers of Excellence to Include Prostate MRI, Enhancing Nation’s Leading Imaging Quality Program

Significant expansion of Covera's proven COE platform launching in 2026; provider applications now open, with…

1 hour ago

Reimagining the Cold Chain: Artyc PBC Introduces Medstow 5L to Power a New Era of Healthcare Logistics

Designed for hospitals, clinical trial sites, and home-care teams, the Medstow 5L Intercampus delivers precise,…

1 hour ago